This compound is a deuterium-labeled active pharmaceutical ingredient featuring a thienopyridine core with a cyclopropyl ketone and fluorophenyl substituent, often used in pharmaceutical manufacturing and research applications.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1127253-02-4
Enrofloxacin hydrochloride
pharmaceutical raw material
(R)-ropivacaine hydrochloride
pharmaceutical raw material
Letrozole
pharmaceutical raw material
4,4'-(1H-1,3,4-triazol-1-ylmethylene)dibenzonitrile
pharmaceutical raw material
Prasugrel
platelet aggregation inhibitor
Prasugrel hydrochloride
pharmaceutical raw material
4-Fluoro prasugrel
pharmaceutical intermediate
3-Fluoro prasugrel
pharmaceutical intermediate
[5-[2-cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-6,7-dihydro-4H-thieno[3,2-c]pyridin-2-yl] 2,2,2-trideuterioacetate
DTGLZDAWLRGWQN-FIBGUPNXSA-N
[2H]C([2H])([2H])C(=O)OC1=CC2=C(S1)CCN(C2)C(C3=CC=CC=C3F)C(=O)C4CC4
—